Phenomix Sciences has entered a partnership with Hello Alpha, a virtual primary care platform, to enable women to take control of their personal healthcare in a convenient, affordable and discreet online process. This first-of-its-kind collaboration gives Hello Alpha's expansive network of providers and patients access to the MyPhenome genetic obesity test, a simple saliva test that identifies a patient's subtype or phenotype, of the disease. Hello Alpha is offering the MyPhenome test alongside weight loss counselling and support to the first 50 eligible patients within its network. The test will be available in September to all new and existing Hello Alpha patients.
The MyPhenome test identifies obesity phenotypes, including Hungry Gut (accelerated gastric emptying), Hungry Brain (a person who consumes too many calories without feeling full), and Emotional Hunger (individuals who eat in response to emotional triggers). Once results are in, providers develop precise and effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations specific to that patient's genetics. Studies have shown obesity treatments tailored to a patient's phenotype(s) are twice as effective as other one-size-fits-all treatments.
"Women face challenges of weight gain particularly with polycystic ovary syndrome (PCOS), pregnancy, and menopause," said Dr Mary T Jacobson, Chief Medical Officer at Hello Alpha. "The Alpha-Phenomix partnership will be a gamechanger for women who seek medical weight loss at all stages of their reproductive health."
More than one in four US women (27.5%) are overweight or experiencing obesity, often facing complex and unique hormonal changes along with societal pressures that influence weight gain throughout their lives. Despite the prevalence of these issues, women's health and obesity still remain under-researched areas in healthcare.
"We are thrilled to launch our first consumer partnership with Hello Alpha. Their holistic treatment approach and team of women's health experts allow us to bring personalized obesity care to new patients across the US," explained Mark Bagnall, CEO of Phenomix Sciences. "Providing convenient access to obesity treatment is key in fighting this global epidemic. Together with Hello Alpha, women now have the resources they need to find the right treatment for their unique type of obesity and support lifelong healthy weight management alongside their provider."
This new partnership aims to address this gap by leveraging Phenomix's expertise in personalised obesity medicine and Hello Alpha's accessible healthcare solutions for women at all life stages. Combining personalised genetic testing with evidence-based treatment is the key to long-term success in patient weight loss journeys.
"Obesity is a complex disease that, much like women's health, needs to be treated holistically. With the help of Phenomix Sciences, we are among the first to offer personalized obesity treatment genetically matched to each woman's needs," said Gloria Lau, CEO of Hello Alpha. "By combining this personalized approach to weight loss with the convenience of telehealth, we're poised to address a key issue in women's health across the US."
Hello Alpha offers a PCP-centric, whole-person care platform built to empower women to take control of their personal healthcare by covering all of her virtual care needs. Each patient gets a dedicated PCP when she signs up, and the same provider cares for all of her primary medical needs online to ensure continuity of care. Now equipped with the MyPhenome test, this provider will guide them through the simple saliva test process, the comprehensive test report that offers personalized context behind the cause of their obesity, and continued care throughout their weight loss journey.
Comments